Goldiam International Bags ₹60 Crore Order for Lab-Grown Diamond Jewellery

Market snapshot: Goldiam International (GOLDIAM) continues its robust momentum in the high-margin lab-grown diamond (LGD) segment, securing a fresh order worth ₹60 crore. This development aligns with the company's aggressive strategy to pivot away from natural diamonds, which now constitute less than 10% of their sales mix. Market sentiment remains positive as the company leverages its net-debt free balance sheet to capture growing US and Middle East export demand.

Data Snapshot

• Order Value: ₹60 Crore
• Recent Q3 FY26 Sales: ₹319.71 Crore
• LGD Revenue Contribution: 90.5%
• Operating Margin (Q3 FY26): 22.12%
• Cash Reserves (Dec 2025): ~₹504 Crore

What's Changed

• Fresh capital inflow via ₹60 crore order boosts near-term revenue visibility for Q1 FY27.
• Revenue mix has shifted from 68.4% LGD in Q1 FY25 to over 90.5% currently, significantly improving gross margins.
• Operational store count for B2C brand ORIGEM expanded to 24 locations in May 2026.

Key Takeaways

• Order win highlights sustained demand for lab-grown diamonds in international markets like the USA.
• Backward integration through in-house diamond growing ensures high margin retention on this ₹60 crore contract.
• The company's net-debt free status provides superior resilience in a volatile commodity market.

SAHI Perspective

Goldiam International's successful transition to a lab-grown diamond-first model is a masterclass in structural adaptation. By securing large-scale orders like this ₹60 crore win, the company validates its supply chain reliability and technical superiority. The recent launch of a 3D Ring Builder and expansion of physical retail stores suggests a powerful dual-track growth engine: high-volume B2B exports and high-margin domestic B2C retail.

Market Implications

The gems and jewellery sector is witnessing a valuation divergence where LGD-focused players like Goldiam are fetching premium multiples compared to traditional natural diamond cut-and-polish firms. This order win signals a capital allocation preference for high-velocity, ethical luxury products. Investors should expect continued outperformance in small-cap jewellery indices as lab-grown demand matures.

Trading Signals

Market Bias: Bullish

The ₹60 crore order represents nearly 20% of historical quarterly revenue, providing solid topline support. Momentum is backed by a 37.5% YoY profit growth in the preceding quarter and an RSI showing near-term strength.

Overweight: Lab-Grown Diamonds, Specialized Jewellery Exports

Underweight: Traditional Natural Diamond Cutting

Trigger Factors:

• Quarterly execution of the ₹60 Cr order
• US consumer sentiment and retail spending data
• Monthly gold price fluctuations influencing hedging costs

Time Horizon: Near-term (0-3 months)

Industry Context

The global lab-grown diamond market is projected to grow from $33.54 billion in 2026 at a CAGR of 13.42%. India remains a global manufacturing hub, benefiting from favorable export policies and the 'Product of Origin' status that mitigates trade tariffs in the US market.

Key Risks to Watch

• Price compression in wholesale LGD markets due to global oversupply.
• Concentration risk with over 80% of revenue coming from the US retail sector.
• Currency volatility affecting export realizations.

Recent Developments

On May 6, 2026, Goldiam launched India's first Digital 3D Ring Builder under its ORIGEM brand. Earlier in May, the stock was upgraded to 'Hold' following record quarterly sales of ₹319.71 crore in Q3 FY26 and a 118% sequential surge in net profit.

Closing Insight

Goldiam International's focus on high-margin, backward-integrated LGD manufacturing places it at the apex of the jewellery value chain. This ₹60 crore win is not just an order; it is evidence of a scaling export engine that prioritizes profitability over commoditized volume.

FAQs

What is the timeline for the ₹60 crore order execution?

While specific dates vary by contract, historical export orders of this size for Goldiam are typically executed within a 3 to 6-month window, impacting the Q1 and Q2 FY27 revenue cycles.

How does the shift to lab-grown diamonds affect Goldiam's profit margins?

Lab-grown diamonds (LGD) offer higher margins due to in-house manufacturing and lower raw material volatility. In Q3 FY26, Goldiam reported operating margins of 22.12%, significantly higher than the 12-15% range typical for natural diamond exporters.

What does this mean for retail investors holding GOLDIAM stock?

The steady flow of ₹60-80 crore orders alongside a net-debt free balance sheet suggests stable cash flow. The company maintains a healthy dividend payout of ~22%, though short-term stock volatility remains high due to its small-cap nature.

High Performance Trading with SAHI.